Moderna Therapeutics

ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More
Xconomy
ASCO 2019
cancer
immunotherapy
diagnostics
Veracyte
Grail
Moderna Therapeutics
Amgen
Nektar Therapeutics
Blueprint Medicines
Merck
AstraZeneca
Roche
breast cancer
Flag link:
June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more
June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more
BioCentury
ASCO 2019
Celgene
Multiple Myeloma
Five Prime Therapeutics
Iovance
Merck
Moderna Therapeutics
Eli Lilly
ICR
Flag link:
Moderna Publishes Influenza Vaccine Clinical Trial Data
Moderna Publishes Influenza Vaccine Clinical Trial Data
BioSpace
Moderna Therapeutics
clinical trials
vaccines
MRNA
H10N8
H7N0
Flag link:
Riding high after its IPO, Moderna chief nabs $59M, biopharma's biggest 2018 paycheck
Riding high after its IPO, Moderna chief nabs $59M, biopharma's biggest 2018 paycheck
Fierce Pharma
Moderna Therapeutics
executive pay
Stephane Bancel
Flag link:
Highlights: American Society of Gene & Cell Therapy Meeting
Highlights: American Society of Gene & Cell Therapy Meeting
BioSpace
gene therapy
cell therapy
Audentes Therapeutics
MaxCyte
Moderna Therapeutics
Translate Bio
Homology Medicines
Flag link:
Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact
Why The Biggest IPO In Biotech History Could Have A 'Disruptive' Impact
Investors Business Daily
Moderna Therapeutics
MRNA
Flag link:
Moderna announces dosing of first monoclonal antibody encoded by mRNA in clinical trial
Moderna announces dosing of first monoclonal antibody encoded by mRNA in clinical trial
Pharmaceutical Business Review
Moderna Therapeutics
MRNA
mRNA-1944
clinical trials
chikungunya virus
Flag link:
Moderna’s Not the Only One: A Look at the mRNA Market
Moderna’s Not the Only One: A Look at the mRNA Market
BioSpace
MRNA
Moderna Therapeutics
Pfizer
BioNTech
CureVac
Translate Bio
Flag link:
Hunting productivity, drugmakers pitch new 'pillars' of R&D
Hunting productivity, drugmakers pitch new 'pillars' of R&D
Biopharma Dive
R&D
Moderna Therapeutics
Sarepta Therapeutics
Ionis Pharmaceuticals
Flag link:
Six Things to Watch for at the JP Morgan Healthcare Conference
Six Things to Watch for at the JP Morgan Healthcare Conference
BioSpace
Moderna Therapeutics
Sarepta Therapeutics
Biogen
Gilead Sciences
Bluebird Bio
Flag link:
Did Moderna break the biotech IPO market?
Did Moderna break the biotech IPO market?
Endpoints
Moderna Therapeutics
IPOs
Flag link:
A Record Year: A Look at the Biotech IPOs for Q4 2018
A Record Year: A Look at the Biotech IPOs for Q4 2018
BioSpace
IPOs
biotech
Moderna Therapeutics
Allogene
Rubius Therapeutics
Kodiak Sciences
Guardant Health
SI Bone
Flag link:
Moderna, largest biotech to go public, fails to impress in market debut
Moderna, largest biotech to go public, fails to impress in market debut
Reuters
IPOs
biotech
Moderna Therapeutics
Flag link:
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever
Moderna Raises $604M and Nails Down Biotech’s Biggest IPO Ever
Xconomy
IPOs
Moderna Therapeutics
Flag link:
Doubts and expectation about Moderna Therapeutics, the superstar among all biotechs
Doubts and expectation about Moderna Therapeutics, the superstar among all biotechs
GoinPharma
Moderna Therapeutics
MRNA
Flag link:
Moderna aims to raise $500 million in biotech’s largest-ever public offering
Moderna aims to raise $500 million in biotech’s largest-ever public offering
Stat
Moderna Therapeutics
IPOs
biotech
Flag link:
Is Moderna prepping for biotech's biggest-ever IPO?
Is Moderna prepping for biotech's biggest-ever IPO?
Fierce Biotech
Moderna Therapeutics
IPOs
messenger RNA
Flag link:
Moderna opens $110M manufacturing site for its mRNA program
Moderna opens $110M manufacturing site for its mRNA program
Fierce Pharma
Moderna Therapeutics
drug manufacturing
MRNA
Flag link:
Moderna’s Billions: Will Building Big Before an IPO Pay Off?
Moderna’s Billions: Will Building Big Before an IPO Pay Off?
Xconomy
Merck
Moderna Therapeutics
IPOs
Flag link:
Moderna boosts unicorn status with a whopping $500M raise and $7B valuation
Moderna boosts unicorn status with a whopping $500M raise and $7B valuation
Endpoints
Moderna Therapeutics
Flag link:

Pages